AN2 Therapeutics, Inc. (ANTX) Ownership

$1.11

$0.02 (1.84%)
Last update: 04:00 PM EST
Day's range
$1.09
Day's range
$1.15

AN2 Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BML CAPITAL MANAGEMENT, LLC 05/07/2025 5.75 M $7.82 M   0.00% 19.13%
ALMITAS CAPITAL LLC 05/15/2025 1.31 M $1.79 B   0.00% 4.37%
VANGUARD GROUP INC 05/09/2025 1.04 M $1.41 M   0.00% 3.45%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 1.00 M $1.36 M   219.88% 3.33%
PFIZER INC 05/13/2025 715.30 K $972.80 M   0.00% 2.38%
04/30/2025 580.85 K $789.96 K   0.35% 1.93%
BANK OF NOVA SCOTIA 05/09/2025 459.19 K $624.50 K   16.29% 1.53%
TWO SIGMA ADVISERS, LP 05/15/2025 445.00 K $605.21 K   -15.77% 1.48%
BANK OF MONTREAL /CAN/ 05/13/2025 422.08 K $574.03 K   0.00% 1.40%
ALDEBARAN CAPITAL, LLC 05/13/2025 406.62 K $553.01 K   18.31% 1.35%
BANK OF AMERICA CORP /DE/ 05/15/2025 385.48 K $524.26 K   0.00% 1.28%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 368.71 K $501.44 K   -36.40% 1.23%
TWO SIGMA INVESTMENTS, LP 05/15/2025 343.96 K $467.79 K   -14.08% 1.14%
BLACKROCK, INC. 05/02/2025 300.69 K $408.93 K   -0.24% 1.00%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 253.92 K $345.42 K   11.47% 0.84%
UBS GROUP AG 05/13/2025 106.02 K $144.19 K   -37.74% 0.35%
STATE STREET CORP 05/15/2025 87.00 K $118.32 K   0.00% 0.29%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 59.90 K $81.46 K   -63.07% 0.20%
MILLENNIUM MANAGEMENT LLC 05/15/2025 50.04 K $68.05 K   -76.10% 0.17%
05/14/2025 50.00 K $68.00 K   100.00% 0.17%
NORTHERN TRUST CORP 05/13/2025 43.20 K $58.75 K   0.00% 0.14%
INTEGRATED WEALTH CONCEPTS LLC 05/15/2025 25.00 K $34.00 K   0.00% 0.08%
LEPERCQ DE NEUFLIZE ASSET MANAGEMENT LLC 05/13/2025 23.23 K $31.60 K   100.00% 0.08%
PRIVATE ADVISOR GROUP, LLC 05/05/2025 22.50 K $30.60 K   0.00% 0.07%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 20.12 K $27.36 K   -25.22% 0.07%
INSPIRION WEALTH ADVISORS, LLC 04/09/2025 18.95 K $25.77 K   100.00% 0.06%
JANE STREET GROUP, LLC 05/19/2025 18.13 K $24.66 K   100.00% 0.06%
FEDERATED HERMES, INC. 05/08/2025 12.24 K $16.64 K   63.33% 0.04%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 10.18 K $13.85 K   -0.01% 0.03%
CAPTRUST FINANCIAL ADVISORS 05/15/2025 10.00 K $13.60 K   -65.12% 0.03%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 2.08 K $2.83 K   42.31% 0.01%
COLDSTREAM CAPITAL MANAGEMENT INC 05/13/2025 783 $1.07 K   100.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 312 $424   0.00% 0.00%
MORGAN STANLEY 05/15/2025 300 $408   0.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 05/12/2025 300 $408   0.00% 0.00%
05/02/2025 200 $272   0.00% 0.00%
JPMORGAN CHASE & CO 05/12/2025 49 $67   -5.77% 0.00%
MARQUETTE ASSET MANAGEMENT, LLC 04/09/2025 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 05/15/2025 0 $0   -100.00% 0.00%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 0 $0   -100.00% 0.00%
SQUAREPOINT OPS LLC 05/15/2025 0 $0   -100.00% 0.00%
XTX TOPCO LTD 05/08/2025 0 $0   -100.00% 0.00%

AN2 Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 43 institutional investors and hedge funds held shares of AN2 Therapeutics, Inc.. The most heavily invested institutionals were:

BML Capital Management, LLC: 5.75 M

Almitas Capital LLC: 1.31 M

VANGUARD GROUP INC: 1.04 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 1,000,000

PFIZER INC: 715,295

BANK OF NOVA SCOTIA: 459,194

47.72% of AN2 Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 14.04 M shares in the last 24 months. This purchase volume represents approximately $15.59 M in transactions.